Sen. Klobuchar calls out Ris­ing Phar­ma for price-goug­ing an old gener­ic drug in short­age

Min­neso­ta De­mo­c­rat Sen. Amy Klobuchar sent a let­ter on Thurs­day to Ris­ing Phar­ma­ceu­ti­cals over the com­pa­ny’s de­ci­sion to price its gener­ic drug to treat lead poi­son­ing at $32,000, which has led hos­pi­tals to no longer af­ford it or car­ry it.

While the FDA al­lowed Ris­ing to bring this poly­va­lent ion chela­tor, known as ede­tate cal­ci­um dis­odi­um, to al­le­vi­ate a short­age, Klobuchar notes that its price is “ten times the price of the im­port­ed ver­sion from France,” which is lead­ing to ac­cess is­sues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER